Insomnia in cancer patients

Area of Science:

• Oncology
• Sleep Medicine
• Psychology

Background:

• Insomnia affects up to 50% of cancer patients, often overlooked compared to pain and fatigue.
• Sleep disturbances negatively impact quality of life, potentially affecting disease course through fatigue, mood changes, and immunosuppression.
• Insomnia is distinct from, yet interrelated with, cancer-related fatigue, with each condition potentially exacerbating the other.

Purpose of the Study:

• To highlight the prevalence and impact of insomnia in cancer patients.
• To emphasize the need for distinguishing insomnia from cancer-related fatigue.
• To outline a multimodal treatment approach for insomnia in this population.

Main Methods:

• Review of existing literature on insomnia in cancer patients.
• Discussion of the relationship between insomnia and cancer-related fatigue.
• Proposal of a combined pharmacologic and nonpharmacologic treatment strategy.

Main Results:

• Insomnia significantly impacts cancer patients' quality of life.
• Effective insomnia management requires addressing underlying conditions like pain, depression, and anxiety.
• A comprehensive approach integrating sleep hygiene, cognitive-behavioral therapy, and pharmacotherapy is recommended.

Conclusions:

• Insomnia is a prevalent and impactful symptom in cancer patients requiring greater attention.
• Multimodal treatment is essential for managing cancer-related insomnia.
• Improving sleep quality enhances overall quality of life for patients with cancer.